Frequently asked questions regarding Dr. Alissa Sue Marr, M.D.
Dr. Alissa Sue Marr, M.D.'s email address is available to verified Dmand AI users. Their primary practice is located at Nebraska Medical Center in Omaha, Nebraska. Sign up for a free trial to reveal their direct contact information.
Dr. Alissa Sue Marr, M.D.'s direct phone number is available to Dmand AI subscribers. To access their direct number, start a free trial.
Dr. Alissa Sue Marr, M.D. is a Medical Oncology Physician physician currently practicing at Nebraska Medical Center in Omaha, Nebraska. They hold admitting privileges at 3 hospital(s), including Nebraska Medical Center. To see all the affiliations of Dr. Alissa Sue Marr, M.D., start a free trial.
Dr. Alissa Sue Marr, M.D. is a board-certified Medical Oncology Physician physician with a subspecialty in Medical Oncology. They practice at Nebraska Medical Center in Omaha, Nebraska.
Dr. Alissa Sue Marr, M.D. performs procedures across 342 clinical categories. Their most commonly billed procedures based on Medicare claims data include , , and . Full procedure and CPT code data is available to Dmand AI subscribers, start a free trial.
Dr. Alissa Sue Marr, M.D.'s National Provider Identifier (NPI) is 1376624924. This is a public identifier issued by CMS and can be verified at the NPPES NPI Registry. Their primary taxonomy code is 207RX0202X, corresponding to Medical Oncology Physician.
The EHR and practice technology used by Dr. Alissa Sue Marr, M.D. at Nebraska Medical Center is available to Dmand AI subscribers. Sign up for a free trial to unlock the full technology stack.
Dr. Alissa Sue Marr, M.D. accepts 0 insurance plans. A full list of accepted payers is available in the profile above.
Dr. Alissa Sue Marr, M.D. holds hospital privileges at 3 institution(s). Their primary affiliation is Nebraska Medical Center in Omaha, Nebraska.
Dr. Alissa Sue Marr, M.D.'s board certification details are available to Dmand AI subscribers.
Dr. Alissa Sue Marr, M.D.'s education history is available to Dmand AI subscribers.
Based on CMS Medicare Part B claims data, Dr. Alissa Sue Marr, M.D. served approximately 174 Medicare beneficiaries in 2023. Total patient volume including non-Medicare patients is available to Dmand AI subscribers.
Dr. Alissa Sue Marr, M.D. is affiliated with UNMC PHYSICIANS, a large (20+ physician) practice with 813 physicians based in Omaha, Nebraska. The practice is independently owned.
Dr. Alissa Sue Marr, M.D. has 28 indexed publications on record and has been listed as a principal investigator on 5 clinical trial(s). Their research activity is available to Dmand AI subscribers. Sign up for a free trial to unlock their full research activity.
Start today — no contract required
Identify. Engage. Convert.
Stop stitching together Definitive, ZoomInfo, and a separate outreach tool. Dmand gives Health IT GTM teams everything they need to find verified healthcare providers and executives, enrich contacts, and book more meetings — in one platform.
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Conditions:Extramammary Paget DiseaseMerkel Cell CarcinomaAnaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine CarcinomaCarcinoma Arising From CylindromaCarcinoma Arising From Spiradenoma
Dr. Alissa Sue Marr, M.D. Practice Locations
NM
Nebraska Medical CenterPrimary
Outpatient & Ambulatory Care • Omaha, NE
BELLEVUE MEDICAL CENTER, LLCAffiliated
Hospital • Bellevue, NE
THE NEBRASKA MEDICAL CENTERAffiliated
Hospital • Omaha, NE
Digital Papillary Adenocarcinoma
Endocrine Mucin-Producing Sweat Gland Carcinoma
Extraocular Sebaceous Carcinoma
Hidradenocarcinoma
Malignant Sweat Gland Neoplasm
Microcystic Adnexal Carcinoma
NK-Cell Lymphoma, Unclassifiable
Papillary Adenocarcinoma
Porocarcinoma
Primary Cutaneous Mucinous Carcinoma
Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
Recurrent T-Cell Non-Hodgkin Lymphoma
Refractory Anaplastic Large Cell Lymphoma
Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma